Poseida Therapeutics

General Information


We are a clinical-stage biopharmaceutical company focused on leveraging our proprietary next-generation, non-viral gene engineering technologies to create life-saving therapeutics for patients with high unmet medical need. We have built a wholly-owned pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumors.

Employees: 52
Founded: 2014
Contact Information
Address 4242 Campus Point Court, Suite 700, San Diego, CA, US
Phone Number (858) 779-3100
Web Address http://www.poseida.com
View Prospectus: Poseida Therapeutics
Financial Information
Market Cap
Revenues $0 mil (last 12 months)
Net Income $-44.4 mil (last 12 months)
IPO Profile
Symbol PSTX
Exchange NASDAQ
Shares (millions): 0.0
Price range $0.00 - $0.00
Est. $ Volume $115.0 mil
Manager / Joint Managers Citigroup/ Credit Suisse/ Wells Fargo Securities
CO-Managers -
Expected To Trade:
Status: TBA
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change